gdc
CLL Monthly Minutes

CLL Monthly Minutes

CLL Monthly MinutesLeukemia
Ongoing clinical trials are poised to expand the role of acalabrutinib in treating chronic lymphocytic leukemia.
CLL Monthly MinutesLeukemia
Chronic lymphocytic leukemia can have a negative effect on patients’ quality of life, but healthcare teams may be able to minimize the impact.
CLL Monthly MinutesLeukemia
Low-dose chemoimmunotherapy may be an effective first-line therapy for certain patients with chronic lymphocytic leukemia and particular biological and genetic features.
CLL Monthly MinutesLeukemia
By keeping themselves physically and emotionally healthy, caregivers can give their loved ones the best possible support when helping to care for them.
CLL Monthly MinutesLeukemia
The COVID-19 pandemic has resulted in several changes in how patients with chronic lymphocytic leukemia (CLL) are treated.
CLL Monthly MinutesLeukemia
Better identification of patients at high risk of disease progression and newer treatments may mean that fewer newly diagnosed patients must “watch and wait.”
CLL Monthly MinutesLeukemia
The use of telemedicine has shown rapid growth over the course of the pandemic, with some experts suggesting that it is here to stay.
CLL Monthly MinutesLeukemia
Can a digital coach improve health outcomes in patients with blood cancers? An ongoing clinical trial should provide insights.
CLL Monthly MinutesLeukemia
Three patients with chronic lymphocytic leukemia were found to have progression to B-ALL after treatment with lenalidomide causing early termination of a clinical study.
CLL Monthly MinutesLeukemia
It is recommended that most patients with CLL receive the COVID-19 vaccine, although each patient should still talk with their healthcare team first.
Page 1 of 3
Results 1 - 10 of 28

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest